메뉴 건너뛰기




Volumn 32, Issue 7, 2013, Pages 1251-1257

Value-based insurance design: Quality improvement but no cost savings

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; SULFONYLUREA;

EID: 84880588402     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2012.0902     Document Type: Article
Times cited : (83)

References (26)
  • 1
    • 33749017051 scopus 로고    scopus 로고
    • The quality of pharmacologic care for adults in the United States
    • Shrank WH, Asch SM, Adams J, Setodji C, Kerr EA, Keesey J, et al. The quality of pharmacologic care for adults in the United States. Med Care. 2006;44(10):936-45.
    • (2006) Med Care , vol.44 , Issue.10 , pp. 936-45
    • Shrank, W.H.1    Asch, S.M.2    Adams, J.3    Setodji, C.4    Kerr, E.A.5    Keesey, J.6
  • 2
    • 60549111800 scopus 로고    scopus 로고
    • Copayment levels and medication adherence: less is more
    • Choudhry NK. Copayment levels and medication adherence: less is more. Circulation. 2009;119(3):365-7.
    • (2009) Circulation , vol.119 , Issue.3 , pp. 365-7
    • Choudhry, N.K.1
  • 3
    • 33947331188 scopus 로고    scopus 로고
    • Value-based insurance design and the next generation of consumer-driven health care
    • DOI: 10.1377/hlthaff.26.2.w204
    • Brennan T, Reisman L. Value-9based insurance design and the next generation of consumer-driven health care. Health Aff(Millwood). 2007; 26(2):w204-7. DOI: 10.1377/hlthaff.26.2.w204.
    • (2007) Health Aff(Millwood) , vol.26 , Issue.2
    • Brennan, T.1    Reisman, L.2
  • 4
    • 0037849900 scopus 로고    scopus 로고
    • The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program
    • Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43(2):173-84.
    • (2003) J Am Pharm Assoc (Wash) , vol.43 , Issue.2 , pp. 173-84
    • Cranor, C.W.1    Bunting, B.A.2    Christensen, D.B.3
  • 5
    • 79952279774 scopus 로고    scopus 로고
    • Assessing the evidence for value-based insurance design
    • Choudhry NK, Rosenthal MB, Milstein A. Assessing the evidence for value-1based insurance design. Health Aff(Millwood). 2010;29(11): 1988-94.
    • (2010) Health Aff(Millwood) , vol.29 , Issue.11 , pp. 1988-94
    • Choudhry, N.K.1    Rosenthal, M.B.2    Milstein, A.3
  • 7
    • 84880591480 scopus 로고    scopus 로고
    • To access the Appendix, click on the Appendix link in the box to the right of the article online
    • To access the Appendix, click on the Appendix link in the box to the right of the article online.
  • 9
    • 38849208528 scopus 로고    scopus 로고
    • Impact of decreasing copayments on medication adherence within a disease management environment
    • Chernew ME, Shah MR, Wegh A, Rosenberg SN, Juster IA, Rosen AB, et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff(Millwood). 2008;27(1):103-12.
    • (2008) Health Aff(Millwood) , vol.27 , Issue.1 , pp. 103-12
    • Chernew, M.E.1    Shah, M.R.2    Wegh, A.3    Rosenberg, S.N.4    Juster, I.A.5    Rosen, A.B.6
  • 10
    • 84900365167 scopus 로고    scopus 로고
    • Reducing copayments for essential cardiovascular medications: evaluation of a natural experiment
    • Choudhry N, Fischer M, Liu J, Lii J, Brookhart A, Shrank W, et al. Reducing copayments for essential cardiovascular medications: evaluation of a natural experiment. J Gen Intern Med. 2010;25:S381-2.
    • (2010) J Gen Intern Med , vol.25
    • Choudhry, N.1    Fischer, M.2    Liu, J.3    Lii, J.4    Brookhart, A.5    Shrank, W.6
  • 11
    • 84867850477 scopus 로고    scopus 로고
    • The impact of reducing cardiovascular medication copayments on health spending and resource utilization
    • Choudhry NK, Fischer MA, Avorn JL, Lee JL, Schneeweiss S, Solomon DH, et al. The impact of reducing cardiovascular medication copayments on health spending and resource utilization. J Am Coll Cardiol. 2012;60(18):1817-24.
    • (2012) J Am Coll Cardiol , vol.60 , Issue.18 , pp. 1817-24
    • Choudhry, N.K.1    Fischer, M.A.2    Avorn, J.L.3    Lee, J.L.4    Schneeweiss, S.5    Solomon, D.H.6
  • 13
    • 84867715386 scopus 로고    scopus 로고
    • The effect of a large regional health plan's value-based insurance design program on statin use
    • Frank MB, Fendrick AM, He Y, Zbrozek A, Holtz N, Leung S, et al. The effect of a large regional health plan's value-2based insurance design program on statin use. Med Care. 2012;50(11):934-9.
    • (2012) Med Care , vol.50 , Issue.11 , pp. 934-939
    • Frank, M.B.1    Fendrick, A.M.2    He, Y.3    Zbrozek, A.4    Holtz, N.5    Leung, S.6
  • 14
    • 79951597073 scopus 로고    scopus 로고
    • Value-based insurance plus disease management increased medication use and produced savings
    • Gibson TB, Mahoney J, Ranghell K, Cherney BJ, McElwee N. Value-based insurance plus disease management increased medication use and produced savings. Health Aff(Millwood). 2011;30(1):100-8.
    • (2011) Health Aff(Millwood) , vol.30 , Issue.1 , pp. 100-108
    • Gibson, T.B.1    Mahoney, J.2    Ranghell, K.3    Cherney, B.J.4    McElwee, N.5
  • 15
    • 79951590391 scopus 로고    scopus 로고
    • A value-based insurance design program at a large company boosted medication adherence for employees with chronic illnesses
    • Gibson TB, Wang S, Kelly E, Brown C, Turner C, Frech-Tamas F, et al. A value-based insurance design program at a large company boosted medication adherence for employees with chronic illnesses. Health Aff(Millwood). 2011;30(1):109-17.
    • (2011) Health Aff(Millwood) , vol.30 , Issue.1 , pp. 109-117
    • Gibson, T.B.1    Wang, S.2    Kelly, E.3    Brown, C.4    Turner, C.5    Frech-Tamas, F.6
  • 16
    • 79952276257 scopus 로고    scopus 로고
    • Copayment reductions generate greater medication adherence in targeted patients
    • Maciejewski ML, Farley JF, Parker J, Wansink D. Copayment reductions generate greater medication adherence in targeted patients. Health Aff(Millwood). 2010;29(11):2002-8.
    • (2010) Health Aff(Millwood) , vol.29 , Issue.11 , pp. 2002-2008
    • Maciejewski, M.L.1    Farley, J.F.2    Parker, J.3    Wansink, D.4
  • 18
    • 74049098412 scopus 로고    scopus 로고
    • Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit
    • Rodin HA, Heaton AH, Wilson AR, Garrett NA, Plocher DW. Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit. Am J Manag Care. 2009; 15(12):881-8.
    • (2009) Am J Manag Care , vol.15 , Issue.12 , pp. 881-888
    • Rodin, H.A.1    Heaton, A.H.2    Wilson, A.R.3    Garrett, N.A.4    Plocher, D.W.5
  • 19
    • 77956360952 scopus 로고    scopus 로고
    • The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation
    • Zeng F, An JJ, Scully R, Barrington C, Patel BV, Nichol MB. The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation. Value Health. 2010;13(6):846-52.
    • (2010) Value Health , vol.13 , Issue.6 , pp. 846-852
    • Zeng, F.1    An, J.J.2    Scully, R.3    Barrington, C.4    Patel, B.V.5    Nichol, M.B.6
  • 20
    • 79951627951 scopus 로고    scopus 로고
    • Value-based benefit design and healthcare utilization in asthma, hypertension, and diabetes
    • Kelly E, Turner C, Frech-Tamas F, Doyle J, Mauceri E. Value-based benefit design and healthcare utilization in asthma, hypertension, and diabetes. Am J Pharm Benefits. 2009;1(4):217-21.
    • (2009) Am J Pharm Benefits , vol.1 , Issue.4 , pp. 217-221
    • Kelly, E.1    Turner, C.2    Frech-Tamas, F.3    Doyle, J.4    Mauceri, E.5
  • 21
    • 38849208528 scopus 로고    scopus 로고
    • Impact of decreasing copayments on medication adherence within a disease management environment
    • Chernew ME, Shah MR, Wegh A, Rosenberg SN, Juster IA, Rosen AB, et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff(Millwood). 2008;27(1):103-12.
    • (2008) Health Aff(Millwood) , vol.27 , Issue.1 , pp. 103-112
    • Chernew, M.E.1    Shah, M.R.2    Wegh, A.3    Rosenberg, S.N.4    Juster, I.A.5    Rosen, A.B.6
  • 23
    • 40549119813 scopus 로고    scopus 로고
    • Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries
    • Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WH. Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation. 2008;117(10):1261-8.
    • (2008) Circulation , vol.117 , Issue.10 , pp. 1261-1268
    • Choudhry, N.K.1    Patrick, A.R.2    Antman, E.M.3    Avorn, J.4    Shrank, W.H.5
  • 24
    • 22344445814 scopus 로고    scopus 로고
    • Cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes
    • Rosen AB, Hamel MB, Weinstein MC, Cutler DM, Fendrick AM, Vijan S. Cost-effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med. 2005;143(2):89-99.
    • (2005) Ann Intern Med , vol.143 , Issue.2 , pp. 89-99
    • Rosen, A.B.1    Hamel, M.B.2    Weinstein, M.C.3    Cutler, D.M.4    Fendrick, A.M.5    Vijan, S.6
  • 26
    • 79952609487 scopus 로고    scopus 로고
    • What do we really know about VBID? Quality of the evidence and ethical considerations for health plan sponsors
    • Fairman KA, Curtiss FR. What do we really know about VBID? Quality of the evidence and ethical considerations for health plan sponsors. J Manag Care Pharm. 2011;17(2): 156-74.
    • (2011) J Manag Care Pharm , vol.17 , Issue.2 , pp. 156-74
    • Fairman, K.A.1    Curtiss, F.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.